Nuvation Bio Inc. (NUVB)

NYSE: NUVB · Real-Time Price · USD

4.420

+0.040 (0.91%)

At close: Mar 26, 2026, 4:00 PM EDT

4.470

+0.050 (1.13%)

After-hours: Mar 26, 2026, 7:28 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Oncology Development Activities	62.90M	7.87M	-	-	-
Oncology Development Activities Growth	698.96%	-	-	-	-
Total	62.90M	7.87M	-	-	-
Total Growth	698.96%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	24.66M	-	-	-	-
China	9.41M	5.15M	-	-	-
China Growth	82.82%	-	-	-	-
Japan	28.83M	2.73M	-	-	-
Japan Growth	957.56%	-	-	-	-
Total	62.90M	7.87M	-	-	-
Total Growth	698.96%	-	-	-	-

Source: S&P Global Market Intelligence.